Watchlist Price Alert

Seelos Therapeutics Inc. (SEEL)

NASDAQ: SEEL · Real-Time Price · USD

0.37

null (null%)

At close: Nov 18, 2024, 9:58 PM

Seelos Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-37.88M	-73.53M	-66.05M	-19.1M	-51.26M	-9.22M	-11.75M	-7.43M
Depreciation & Amortization	57K	53K	1.58M	150K	n/a	41K	117K	289K
Stock-Based Compensation	3.99M	5.07M	8.35M	2.04M	459K	1.3M	1.14M	1.75M
Other Working Capital	-358K	850K	-1.21M	-5.64M	8.29M	-498K	-498K	-210K
Other Non-Cash Items	-2.49M	4.02M	10.11M	689K	24.63M	92K	58K	823K
Deferred Income Tax	n/a	n/a	-1.58M	-150K	n/a	-24K	1.17M	-7.47M
Change in Working Capital	12.42M	2.78M	-1.41M	-4.54M	6.86M	-321K	-1.2M	-1.02M
Operating Cash Flow	-23.91M	-61.6M	-48.99M	-20.91M	-19.3M	-8.13M	-10.47M	-13.07M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-18K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3K
Purchase of Investments	n/a	n/a	n/a	6.37M	5.92M	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	-3K	12.21M	283K
Investing Cash Flow	n/a	n/a	n/a	6.37M	5.92M	-3K	12.21M	265K
Debt Repayment	-7.64M	-1.89M	-13.55M	147K	n/a	n/a	-7.13M	n/a
Common Stock Repurchased	-1.2M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	97K	-166K	7.46M	45K	4.52M	585K	-1.1M	-3.12M
Financial Cash Flow	11.38M	-1.6M	112.07M	26.31M	29.52M	5.38M	2.5M	11M
Net Cash Flow	-12.54M	-63.2M	63.07M	5.4M	10.22M	-2.75M	4.24M	-1.8M
Free Cash Flow	-23.91M	-61.6M	-48.99M	-20.91M	-19.3M	-8.13M	-10.47M	-13.09M